AK102
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for AK102, covering 2023-03-02 to 2025-03-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia [Phase 3]